• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Obstetrics

Customized criteria for fetal growth predictive of neonatal outcomes

byDenise PongandLeah Hawkins Bressler, MD, MPH
November 8, 2015
in Obstetrics
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Infants classified as small for gestational age (SGA) by INTERGROWTH-21 and customized criteria were more likely to experience stillbirth, neonatal morbidity and death.

2. Infants classified as SGA by INTERGROWTH-21 criteria alone was not associated with increased risk for adverse outcomes.

Evidence Rating Level: 2 (Good)

Study Rundown: Growth restriction occurs when a fetus has not reached its expected growth and can occur as a result of fetal, placental and/or maternal factors. While SGA is defined as birth weight below the 10th percentile for gestational age, this definition does not distinguish between infants who are constitutionally small and those that are growth-restricted. This distinction is clinically significant, as infants with fetal growth restriction are at greater risk for premature delivery, impaired thermoregulation, neonatal death, as well as growth and neurodevelopmental abnormalities. INTERGROWTH-21 is a growth standard that has been used in multiple countries and posited by researchers and clinicians as a useful tool in the assessment of infant anthropometrics. In the present work, the authors evaluated the ability of INTERGROWTH-21 compared to customized standards for SGA to identify infants at risk for adverse outcomes. They found that classification as SGA by either customized standards alone or using both standards was associated with increased risk for adverse perinatal outcomes. Classification as SGA by INTERGROWTH-21 criteria alone was not associated with increased risk for adverse outcomes.

Strengths of the study were large population-based data and comparison of INTERGROWTH-21 criteria to a standard model. The study was limited by post-hoc analysis and limited generalizability to populations of different ethnic composition. Further evaluation of INTERGROWTH-21 in prospective studies is needed to clarify its role in predicting adverse perinatal outcomes.

Click to read the study in the AJOG (American Journal of Obstetrics and Gynecology)

RELATED REPORTS

Anti-psychotic medication use during pregnancy not associated with attention-deficit/hyperactivity disorder, autism spectrum disorder or small for gestational age in children

Quick Take: Small for gestational age and risk of childhood mortality: A Swedish population study

Relevant Reading: Small for gestational age infants classified by customized or population birthweight centiles: impact of gestational age at delivery

In-Depth [prospective cohort]: This secondary analysis of prospectively collected population-based data compared the ability of the INTERGROWTH-21 criteria and customized standards for SGA to predict perinatal outcomes in over 53,000 singleton pregnancies. Factors included in the customized standards model were maternal height, weight, parity, ethnicity and infant sex. The primary outcomes of interest were stillbirth, neonatal death, and neonatal morbidity.

Infants classified as SGA by both criteria were most likely to experience neonatal death or morbidity (RR 4.1, CI 3.7-4.6) and stillbirth (RR 8.3, CI 5.1-13.4). Infants classified as SGA by customized criteria alone experienced a lesser increased risk of (RR 2.0, CI 1.8-2.2) and stillbirth (RR 3.0, CI 1.7-5.3) while those classified as SGA by INTERGROWTH-21 criteria alone did not experience increased risks of adverse outcomes. Sensitivity and specificity of INTERGROWTH-21 were 14.3% and 96.1% respectively compared to 26.6% and 89.2% with the customized standard.

Image: CC/Wiki/Wellcome Images

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: growth restrictionsmall for gestational age (SGA)
Previous Post

Epileptogenic foci may be lateralized using functional brain glutamate imaging

Next Post

Higher pre-pregnancy BMI linked to adverse adolescent cardio-metabolic profile

RelatedReports

Obstetrics

Anti-psychotic medication use during pregnancy not associated with attention-deficit/hyperactivity disorder, autism spectrum disorder or small for gestational age in children

August 23, 2021
Obstetrics

Quick Take: Small for gestational age and risk of childhood mortality: A Swedish population study

December 27, 2018
Weekly Rewinds

2 Minute Medicine Rewind December 24, 2018

December 26, 2018
Obstetrics

History of maternal anorexia linked to small infant size

January 2, 2016
Next Post

Higher pre-pregnancy BMI linked to adverse adolescent cardio-metabolic profile

Significant amount of unhealthy children’s foods marketed to parents

Nebulized saline not associated with bronchiolitis hospital length of stay

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality
  • In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications
  • Continuation of immunotherapy after immune checkpoint inhibitor-induced myocarditis in patients with lung cancer may be safe and effective
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.